Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 1.000 | |
| 2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.689 | |
| 2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.613 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.534 | |
| 4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.514 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.508 | |
| 4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.499 | |
| 1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.497 | |
| 1jst | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
| 4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.488 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
| 4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
| 4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.480 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.479 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.478 | |
| 4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.477 | |
| 4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
| 4i5c | C5I | Tyrosine-protein kinase JAK1 | / | 0.476 | |
| 3qcx | 3Q2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.473 | |
| 4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.472 | |
| 4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.471 | |
| 4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.471 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.471 | |
| 4nif | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.471 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.469 | |
| 1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.466 | |
| 1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
| 4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.464 | |
| 1zp9 | ATP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.461 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.458 | |
| 1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.456 | |
| 2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.455 | |
| 4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.455 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.454 | |
| 3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.452 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.452 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.450 | |
| 4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
| 4oau | ADP | 2-5A-dependent ribonuclease | 3.1.26 | 0.449 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.448 | |
| 2pml | ANP | Uncharacterized protein | / | 0.447 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.447 | |
| 1jnk | ANP | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.445 | |
| 4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.445 | |
| 3oro | AGS | Serine/threonine protein kinase | / | 0.444 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 1tvo | FRZ | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.443 | |
| 3nie | ANP | Mitogen-activated protein kinase | / | 0.443 | |
| 4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.443 | |
| 4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.442 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
| 3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 4ux9 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.441 | |
| 3llt | ANP | Protein serine/threonine kinase-1 | / | 0.440 |